HOOK Projected Dividend Yield
HOOKIPA Pharma Inc ( NASDAQ : HOOK )HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Co.'s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. 21 YEAR PERFORMANCE RESULTS |
HOOK Dividend History Detail HOOK Dividend News HOOK Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |